Showing results (31-40 of 472) with videos related to

Sort By:
Pageof 48
Journal of Vascular Surgery|March 23, 2025
An audit of physical waste and fluoroscopy energy consumption in vascular surgery and suggestions for the futureOmar Moussa Pasha, Aidan Rowe, David P Ebertz, et al.
Biochemical Pharmacology|May 1, 2012
Phenylalanine 368 of multidrug resistance-associated protein 4 (MRP4/ABCC4) plays a crucial role in substrate-specific transport activityHanneke G M Wittgen, Jeroen J M W van den Heuvel, Elmar Krieger, et al.
Surgical Endoscopy|July 1, 1993
Proximal gastric vagotomy by minimally invasive methods in an acute rat modelC M Wittgen, T A Schneider, S D Fitzgerald, et al.
Toxicological Sciences : an Official Journal of the Society of Toxicology|October 30, 2012
Interaction of digitalis-like compounds with p-glycoproteinElnaz Gozalpour, Hanneke G M Wittgen, Jeroen J M W van den Heuvel, et al.
Vascular|April 11, 2022
Depression screening in patients with vascular diseaseRachel R Fan, Samuel B Rudnick, Hataka R Minami, et al.
The Thoracic and Cardiovascular Surgeon|August 17, 2018
Acute Effect of Mitral Valve Repair on Mitral Valve GeometryThilo Noack, Kathleen Wittgen, Philipp Kiefer, et al.
AJOB Empirical Bioethics|January 12, 2016
Perspectives of Decisional Surrogates and Patients Regarding Critical Illness Genetic ResearchBradley D Freeman, Dragana Bolcic-Jankovic, Carie R Kennedy, et al.
American Journal of Physiology. Renal Physiology|October 10, 2008
Conditional fast expression and function of multimeric TRPV5 channels using Shield-1Joost P H Schoeber, Stan F J van de Graaf, Kyu Pil Lee, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|April 23, 2011
Cannabinoid type 1 receptor antagonists modulate transport activity of multidrug resistance-associated proteins MRP1, MRP2, MRP3, and MRP4Hanneke G M Wittgen, Jeroen J M W van den Heuvel, Petra H H van den Broek, et al.
Molecular Pharmaceutics|March 21, 2012
Exploiting transport activity of p-glycoprotein at the blood-brain barrier for the development of peripheral cannabinoid type 1 receptor antagonistsHanneke G M Wittgen, Rick Greupink, Jeroen J M W van den Heuvel, et al.
Pageof 48